Nauzene
- Product NDC
- 52389-242
- Requested package NDC
- 52389-242-40
- 11-digit product format
- 523890242
- Labeler code
- 52389
- Product ID
- 52389-242_2d7c94e6-382b-1655-e063-6394a90a712d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sodium Citrate
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Kobayashi Healthcare International, Inc.
- Application
- M001
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2000-07-08
- Substance
- TRISODIUM CITRATE DIHYDRATE
- Active strength
- 230 mg/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 52389-242 | 52389-242-40 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52389-242 | 52389-242-40 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52389-242 | 52389-242-40 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nauzene
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TRISODIUM CITRATE DIHYDRATE | 230 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| B22547B95K | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2002800 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a60660b2-c5db-45a0-885f-de93e655380d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52389-242-10 | Nauzene | 1 in 1 CARTON | TABLET, CHEWABLE | 1 | 15 | |
| 52389-242-10 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-40 | Nauzene | 4 in 1 CARTON | TABLET, CHEWABLE | 4 | 15 | |
| 52389-242-40 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-42 | Nauzene | 14 in 1 BLISTER PACK | TABLET, CHEWABLE | 14 | 15 | |
| 52389-242-42 | Nauzene | 3 in 1 CARTON | TABLET, CHEWABLE | 3 | 15 | |
| 52389-242-50 | Nauzene | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 15 | |
| 52389-242-50 | Nauzene | 5 in 1 CARTON | TABLET, CHEWABLE | 5 | 15 | |
| 52389-242-56 | Nauzene | 14 in 1 BLISTER PACK | TABLET, CHEWABLE | 14 | 15 | |
| 52389-242-56 | Nauzene | 4 in 1 CARTON | TABLET, CHEWABLE | 4 | 15 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ultra Strength | CALCIUM CARBONATE | BETTER LIVING BRANDS LLC | 35b3d9d0-b04d-4f6d-b99d-435233803d4b | 2026-10-30 | Warnings | M001 |
| Ultra Strength | CALCIUM CARBONATE | BETTER LIVING BRANDS LLC | 3ff92c9a-987f-468e-9e18-1e3e171ede14 | 2026-10-30 | Warnings | M001 |
| Extra Strength | CALCIUM CARBONATE | BETTER LIVING BRANDS, LLC | 9b311b76-1892-4b74-a07a-8b321436d4a0 | 2026-10-30 | Warnings | M001 |
| Quality Choice Regular Strength Peppermint Flavor | CALCIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION | ea1abf51-7d10-4b1f-8eca-c5f94892bfe7 | 2026-10-29 | Warnings | M001 |
| QC Regular Strength | ANTACID | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 1dd6df9a-241b-4a85-b31a-0741e916ae46 | 2026-10-29 | Warnings | M001 |
| Quality Choice Assorted Berries Extra Strength | CALCIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION | c7f26b0a-f2c4-4ed2-9673-52f90d1a41c9 | 2026-10-29 | Warnings | M001 |
| Quality Choice Ultra Strength Assorted Fruit | CALCIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION | 63318b46-d47d-474c-8fb5-5e0d53b7adb4 | 2026-10-29 | Warnings | M001 |
| Calcium Carbonate Antacid Assorted Berries | CALCIUM CARBONATE | Anhui Jiuhe Health Industry Co., Ltd | 5efcff9f-b935-0de6-e063-6394a90aa932 | 2026-10-29 | Warnings | M001 |
| Tums Chewy Bites Strawberries and Cream | CALCIUM CARBONATE | Haleon US Holdings LLC | ed861325-bd69-42fe-b901-e15add028c7a | 2026-10-29 | Warnings | M001 |
| Extra Strength Antacid Original Flavor | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION INC. | 8064b01a-e049-4d49-a5b6-e72dbeb5daac | 2026-10-29 | Warnings | M001 |
| QC Antacid Calcium Assorted Berry | CALCIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION INC. | 82f5e540-a1b2-48e2-9b1d-ff52c29f7835 | 2026-10-29 | Warnings | M001 |
| Quality Choice Chewable Antacid Assorted Fruit | ANTACID TABLETS | Chain Drug Marketing Association | c1171d19-5694-4e6c-9865-40c5f62c4f05 | 2026-10-28 | Warnings | M001 |
| Quality Choice Antacid Assorted Fruit | CALCIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION | bfb80841-edda-482b-b401-e5f1cd52440e | 2026-10-28 | Warnings | M001 |
| Heartburn and gas fruit chews | CALCIUM CARBONATE | CVS Pharmacy | 4a656a9f-8f34-69b7-e054-00144ff8d46c | 2026-10-27 | Warnings | M001 |
| CVS Mixed Berry Antacid HBG 54ct | CALCIUM CARBONATE | CVS Pharmacy | e9204edb-e4d9-3975-e053-2995a90ac6a9 | 2026-10-27 | Warnings | M001 |
| QUALITY CHOICE Original Flavor | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | CHAIN DRUG MARKETING ASSOCIATION INC. | a699b830-6400-4af9-9810-5eda79157333 | 2026-10-27 | Warnings | M001 |
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2026-10-26 | Warnings | M001 |
| Mag 440 | MEGNESIUM OXIDE | Allegis Pharmaceuticals, LLC | 2cb19dc0-115b-38b8-e063-6294a90a4aea | 2026-10-26 | Warnings | M001 |
| magnesium oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc. | dc57893c-068a-37d8-e053-2a95a90aa054 | 2026-10-26 | Warnings | M001 |
| Magnesium Oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc | 0bb322a5-fb92-14de-e063-6294a90a4c1b | 2026-10-26 | Warnings | M001 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2002800 | sodium citrate 230 MG Chewable Tablet | PSN | a60660b2-c5db-45a0-885f-de93e655380d | 15 |
| 2002800 | sodium citrate 230 MG Chewable Tablet | SCD | a60660b2-c5db-45a0-885f-de93e655380d | 15 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 52389-242-40 | 52389024240 | 4 BLISTER PACK in 1 CARTON (52389-242-40) > 10 TABLET, CHEWABLE in 1 BLISTER PACK | 4 blister pack | 2000-07-08 | 0000-00-00 | No | No | Current |